Scoria Pharmaceuticals Private Limited, a active private limited company, was established on 08 August 2003 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239DL2003PTC121713. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Surjeet Ray (Director), Shashi Dhiman (Director). Past directors included Dharam Pal Singh Sehrawat, Surjeet Ray, Kunal Kumar Dhiman. It holds ₹5.97 M open charges and no settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at Wz-295, 2Nd Floor, Gali No 10, Lajwanti Garden, New Delhi, Delhi, 110046.
U24239DL2003PTC121713
121713
08 August 2003
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Scoria Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surjeet Ray | Director | 10 Oct 2018 | Current |
| Shashi Dhiman | Director | 31 Oct 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Oct 2009 | Past |
| Pramod Abcsdd | Director | 31 Dec 2016 | Past |
| Pramod Abcsdd | Director | 23 Nov 2015 | Past |
| Pramod Abcsdd | Director | 10 Nov 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scoria Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 33.25% decrease. The company also saw a substantial fall in profitability, with a 30.34% decrease in profit. The company's net worth moved up by a moderate rise of 5.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Scoria Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,974,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2020 | Others | ₹0.97 M | Open |
| 25 Oct 2013 | Punjab National Bank | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Scoria Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Scoria Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scoria Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Scoria Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
Scoria Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.97 M with Charge ID 100356277 was registered on 10 Jul 2020. was completed.
Surjeet Ray was appointed as a Director was appointed as a Director on 10 Oct 2018 & has been associated with this company since 7 years 1 month . was recorded as a recent event.
Shashi Dhiman was appointed as a Director was appointed as a Director on 31 Oct 2015 & has been associated with this company since 10 years 29 days . was recorded as a recent event.
A charge with Punjab National Bank of Rs. 5.00 M registered on 25 Oct 2013 with Charge ID 10456490 was modified on 27 May 2015. was recorded as a recent event.
The CIN of Scoria Pharmaceuticals Private Limited is U24239DL2003PTC121713.
Scoria Pharmaceuticals Private Limited is headquartered at Wz-295, 2Nd Floor, Gali No 10, Lajwanti Garden, New Delhi, Delhi, 110046.
Scoria Pharmaceuticals Private Limited was incorporated on 08 August 2003.
The current directors of Scoria Pharmaceuticals Private Limited are
The primary industry of Scoria Pharmaceuticals Private Limited is Trade.
Scoria Pharmaceuticals Private Limited is unlisted.
The authorized capital of Scoria Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Scoria Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX